Back to Journals » OncoTargets and Therapy » Volume 9
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,038 | Dovepress* | 9,106+ | 1,515 | 10,621 | |
PubMed Central* | 932 | 340 | 1,272 | ||
Totals | 10,038 | 1,855 | 11,893 | ||
*Since 30 December 2015 +Since July 2016 |
View citations on PubMed Central and Google Scholar